Birdshot chorioretinopathy is a rare eye condition. It causes small, white spots to appear in the back of the eye, usually around the optic nerve. These spots are often symmetrical. The exact cause isn't fully understood, but it's often linked to a specific gene (HLA-A29). It can lead to vision problems if not treated.
Every report comes from a Lived member, sent anonymously.
Have you tried Humira (Adalimumab) for Birdshot Chorioretinopathy?
Birdshot chorioretinopathy is a rare, long-lasting inflammation at the back of both eyes. It affects the retina, the light-sensing layer that lines the inside of the eye, and the choroid, the layer of blood vessels just beneath it. Doctors group it with the posterior uveitis conditions, meaning inflammation in the back part of the eye. It is thought to be autoimmune, with the immune system targeting the eye, and unlike many forms of uveitis it does not affect any other part of the body. The name comes from what an eye doctor sees: small cream-colored oval spots scattered around the optic nerve, resembling the spray pattern of birdshot pellets from a shotgun. People most often notice blurred vision, floaters and trouble seeing at night or in dim light. Some also notice dulled colors, poor contrast, shimmering or flickering vision or gaps in their side vision. Eye pain, redness and light sensitivity are unusual. Because sharp central vision can be preserved for a long time, the disease may be quietly damaging the retina even when someone still reads the eye chart well.
The exact cause is unknown, but birdshot has one of the strongest genetic links of any disease. More than 95% of people with it carry a gene variant called HLA-A29, one of the HLA genes, which help the immune system tell the body's own cells from invaders. Carrying HLA-A29 is far from a diagnosis, though: roughly 7 to 9% of people of European descent carry it, and almost all of them never develop birdshot. Researchers think other immune and genetic factors are needed for the disease to start. Birdshot usually begins in middle age, on average in the early fifties, and occurs almost only in adults. Most people affected are white and of European ancestry. Despite the name, it has nothing to do with birds or bird exposure, and there is no known trigger to avoid.
Birdshot is diagnosed by an eye specialist, often one who focuses on uveitis, from a careful examination of the back of the eye after the pupils are dilated. The typical picture is the cream-colored spots in both eyes with little inflammation in the front of the eye and mild to moderate haze in the vitreous, the clear gel inside the eye. A blood test for HLA-A29 strongly supports the diagnosis. A negative result makes birdshot unlikely and prompts a search for another cause. Imaging helps confirm the diagnosis and shows how active it is. Optical coherence tomography (OCT) is a quick light scan that shows the retina's layers in cross-section and can detect swelling. Angiography, in which a dye is injected into an arm vein and the eye is photographed as it passes through, can reveal leaky blood vessels and spots that are not visible on examination. Visual field testing maps side vision, and an electroretinogram (ERG) measures how the retina responds to flashes of light. These matter because side vision, color and contrast can be affected even when someone sees 20/20 on the chart. Several infections and other diseases can look similar, so a workup usually includes tests to rule out syphilis, tuberculosis and sarcoidosis (an inflammatory disease that can affect the eyes and lungs), and occasionally lymphoma inside the eye.
Treatment aims to calm the inflammation and protect vision over the long term. It cannot repair retina that has already been lost, which is one reason specialists often favor treating early. There are no clinical trials devoted to birdshot alone and no agreed standard plan, so choices draw on experience with other forms of uveitis and on the person's activity level, other health conditions and preferences. Corticosteroids act quickly and are commonly used to control flares. Taken by mouth at high doses for a long time, they cause substantial side effects, so they are usually a bridge rather than a long-term answer. Steroids can also be delivered into or around the eye, for example with a slow-release dexamethasone implant (Ozurdex), which is useful for swelling in the center of the retina. Eye-directed steroids commonly speed cataract formation and can raise eye pressure, leading to glaucoma, so eye pressure is checked regularly afterward. For lasting control, most people need a steroid-sparing medicine that dampens the immune system. Options include mycophenolate, methotrexate, azathioprine, and cyclosporine or tacrolimus, which restrain the T cells that drive inflammation. Mycophenolate and methotrexate can harm a pregnancy, so anyone who could become pregnant should discuss contraception and family plans before starting. When these are not enough, a biologic medicine such as adalimumab (Humira), which blocks an inflammatory signal called TNF and is approved for non-infectious uveitis at the back of the eye, may be added. Observational studies suggest that steroid-sparing medicines lower the rate of flares and of retinal swelling and help preserve vision, and adalimumab's approval rests on uveitis trials that included some people with birdshot. All of these medicines raise the risk of infections and require regular blood tests; adalimumab's label carries a boxed warning, the strongest US drug warning, for serious infections, including tuberculosis. Some people whose disease stays quiet for a couple of years can slowly taper treatment under close monitoring.
Birdshot is usually a long-term condition. Its course varies widely: a small group of people keep good vision for many years with little treatment, while most have repeated periods of active inflammation, and vision can slowly decline without adequate control. The most common cause of lost vision is macular edema, swelling of the macula, the small central area of the retina used for reading and recognizing faces. Most people develop it at some point, which is one reason regular scans matter: swelling picked up on a scan can be treated before it does lasting harm. Over many years, scarring and thinning of the retina can reduce night vision, side vision and color vision, and a minority of people eventually lose enough vision to be considered legally blind. Day to day, night driving and dim settings are often the first things to become harder. Living with birdshot means regular visits to an eye specialist, with imaging and vision tests to catch activity before it causes damage, plus blood tests for those on immune-suppressing medicines. Treatment is often needed for years, and finding a regimen that controls inflammation with tolerable side effects can take time.
See an eye specialist if floaters, blurred vision or difficulty seeing at night come on gradually and do not settle; a dilated eye examination is the way to find birdshot. If you already have birdshot, contact your eye team soon, rather than waiting for the next scheduled visit, if your vision becomes noticeably blurrier or new floaters appear, or if you develop eye pain, redness or light sensitivity, which are unusual for birdshot and may point to a different problem. If you take an immune-suppressing or biologic medicine, call your prescriber promptly about a fever or other signs of infection. Whether or not you have birdshot, a sudden burst of new floaters, flashes of light or a shadow spreading across your vision needs an eye examination the same day, because it can signal a torn or detached retina.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Birdshot Chorioretinopathy is like, what's helped you, or ask the community a question.